Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Consumer & Luxury

The Final Chapter for Hanesbrands as a Public Company

Andreas Sommer by Andreas Sommer
December 2, 2025
in Consumer & Luxury, Market Commentary, Mergers & Acquisitions
0
Hanesbrands Stock
0
SHARES
90
VIEWS
Share on FacebookShare on Twitter

The independent story of Hanesbrands on the public markets has reached its conclusion. The apparel maker’s acquisition by Canadian competitor Gildan Activewear, valued at approximately $2.2 billion, was finalized, leading to the cessation of its stock listing on the New York Stock Exchange effective December 1, 2025.

Shareholder Compensation and New Ownership

Remaining equity holders received a definitive exchange offer. For each share of Hanesbrands they owned, investors were granted $0.80 in cash plus 0.102 shares of the acquiring firm, Gildan. This transaction results in former Hanesbrands shareholders collectively owning an estimated 19.9% stake in the newly combined entity. The investment narrative for Hanesbrands as a standalone stock is now closed.

Full Market Exit and Delisting Process

The withdrawal from public trading is comprehensive. Concurrent with the halt in stock trading, the company was removed from all options exchanges within the MIAX Exchange Group, including MIAX Options and MIAX Pearl. The official delisting was executed through the filing of a Form 25 with the U.S. Securities and Exchange Commission (SEC), eliminating all remaining liquidity for the security.

Should investors sell immediately? Or is it worth buying Hanesbrands?

Strategic Ambitions of a Combined Powerhouse

The merger creates a dominant force in the basic apparel sector. The unified company is projected to generate annual revenue of roughly $6.9 billion, effectively doubling Gildan’s previous scale. Management is targeting significant synergies from the deal:

  • Annual cost savings of at least $200 million, to be realized within a three-year timeframe.
  • Analysts at Stifel Bank project an 18% boost to earnings per share (EPS accretion) in the first year following the merger.
  • Long-term, this positive earnings impact could potentially reach up to 40% as synergies are fully realized.

The strategic focus is firmly on expanding the Hanes underwear business. As the corporate headquarters in Winston-Salem faces an uncertain future regarding its structure, Gildan is integrating the acquired brands and distribution networks into its global strategy. Market attention now shifts entirely to Gildan’s stock.

Ad

Hanesbrands Stock: Buy or Sell?! New Hanesbrands Analysis from March 25 delivers the answer:

The latest Hanesbrands figures speak for themselves: Urgent action needed for Hanesbrands investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

Hanesbrands: Buy or sell? Read more here...

Tags: Hanesbrands
Andreas Sommer

Andreas Sommer

About Andreas Sommer Over 40 years of expertise in market analysis, chart technical analysis, and strategic investment advisory. With more than four decades of experience in banking and financial journalism, Andreas Sommer is recognized as one of the leading analysts in the German-speaking market. His deep understanding of market dynamics and technical analysis has helped countless investors navigate complex financial markets.
Areas of Expertise:
  • Technical Chart Analysis
  • Strategic Investment Advisory
  • Market Trend Analysis
  • Financial Journalism
Andreas brings unparalleled insights from his extensive career in banking and financial markets, making him a trusted voice for investors seeking professional guidance.

Related Posts

Hain Celestial Stock
Analysis

Hain Celestial Sheds Snack Division in Strategic Overhaul

March 25, 2026
Technology Select Sector SPDR® Fund Stock
AI & Quantum Computing

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

March 25, 2026
Coinbase Stock
Analysis

Regulatory Proposal Sparks Sell-Off in Coinbase Shares

March 25, 2026
Next Post
Carrefour PK Stock

Carrefour Completes Strategic Exit from Italy

QuantumScape Stock

Insider Selling and Analyst Downgrades Cloud QuantumScape's Outlook

Encore Wire Stock

Prysmian's Strategic US Investment Earns Top Transatlantic Honor

Recommended

Alphabet Stock

Alphabet Shares Face Regulatory Headwinds Despite Autonomous Driving Breakthrough

4 months ago
Dish Network Stock

Institutional Investors Show Diverging Views on Dish Network’s Future

7 months ago
Finance_ Trading ratings today (2)

Lakeland Financial Exceeds Expectations with Fourth Quarter Earnings

2 years ago
DeFi Technologies Stock

DeFi Technologies: Navigating Expansion Amidst Legal Headwinds

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Hain Celestial Sheds Snack Division in Strategic Overhaul

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

Lumen’s AI Infrastructure Push Gains Recognition Amid Strategic Overhaul

Microsoft’s AI Ambitions Strain Finances as Cash Reserves Shrink

Trending

BioNano Genomics Stock
Analysis

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

by Kennethcix
March 25, 2026
0

BioNano Genomics has wrapped up its fiscal year 2025, presenting a financial picture marked by significant operational...

Humacyte Stock

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

March 25, 2026
Evolent Health Stock

Evolent Health Bets on AI Leadership Amid Share Price Decline

March 25, 2026
MongoDB Stock

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

March 25, 2026
Talphera Stock

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds
  • Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts
  • Evolent Health Bets on AI Leadership Amid Share Price Decline

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com